Literature DB >> 32038042

Probing the role of the conserved residue Glu166 in a class A β-lactamase using neutron and X-ray protein crystallography.

Patricia S Langan1, Brendan Sullivan1, Kevin L Weiss1, Leighton Coates1.   

Abstract

The amino-acid sequence of the Toho-1 β-lactamase contains several conserved residues in the active site, including Ser70, Lys73, Ser130 and Glu166, some of which coordinate a catalytic water molecule. This catalytic water molecule is essential in the acylation and deacylation parts of the reaction mechanism through which Toho-1 inactivates specific antibiotics and provides resistance to its expressing bacterial strains. To investigate the function of Glu166 in the acylation part of the catalytic mechanism, neutron and X-ray crystallographic studies were performed on a Glu166Gln mutant. The structure of this class A β-lactamase mutant provides several insights into its previously reported reduced drug-binding kinetic rates. A joint refinement of both X-ray and neutron diffraction data was used to study the effects of the Glu166Gln mutation on the active site of Toho-1. This structure reveals that while the Glu166Gln mutation has a somewhat limited impact on the positions of the conserved amino acids within the active site, it displaces the catalytic water molecule from the active site. These subtle changes offer a structural explanation for the previously observed decreases in the binding of non-β-lactam inhibitors such as the recently developed diazobicyclooctane inhibitor avibactam.

Entities:  

Keywords:  Toho-1; X-ray diffraction; antibiotics; neutron diffraction; β-lactamases

Mesh:

Substances:

Year:  2020        PMID: 32038042      PMCID: PMC7008513          DOI: 10.1107/S2059798319016334

Source DB:  PubMed          Journal:  Acta Crystallogr D Struct Biol        ISSN: 2059-7983            Impact factor:   7.652


  29 in total

Review 1.  Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes.

Authors:  R Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

2.  Joint X-ray and neutron refinement with phenix.refine.

Authors:  Pavel V Afonine; Marat Mustyakimov; Ralf W Grosse-Kunstleve; Nigel W Moriarty; Paul Langan; Paul D Adams
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-10-20

3.  The acylation mechanism of CTX-M beta-lactamase at 0.88 a resolution.

Authors:  Yu Chen; Richard Bonnet; Brian K Shoichet
Journal:  J Am Chem Soc       Date:  2007-04-05       Impact factor: 15.419

4.  Kinetics of avibactam inhibition against Class A, C, and D β-lactamases.

Authors:  David E Ehmann; Haris Jahic; Philip L Ross; Rong-Fang Gu; Jun Hu; Thomas F Durand-Réville; Sushmita Lahiri; Jason Thresher; Stephania Livchak; Ning Gao; Tiffany Palmer; Grant K Walkup; Stewart L Fisher
Journal:  J Biol Chem       Date:  2013-08-02       Impact factor: 5.157

5.  The catalytic efficiency (kcat/Km) of the class A beta-lactamase Toho-1 correlates with the thermal stability of its catalytic intermediate analog.

Authors:  Yasushi Nitanai; Tatsuro Shimamura; Takuro Uchiyama; Yoshikazu Ishii; Michiyo Takehira; Katsuhide Yutani; Hiroshi Matsuzawa; Masashi Miyano
Journal:  Biochim Biophys Acta       Date:  2009-10-31

6.  Relocation of the catalytic carboxylate group in class A beta-lactamase: the structure and function of the mutant enzyme Glu166-->Gln:Asn170-->Asp.

Authors:  C C Chen; O Herzberg
Journal:  Protein Eng       Date:  1999-07

7.  Mechanisms of proton relay and product release by Class A β-lactamase at ultrahigh resolution.

Authors:  Eric M Lewandowski; Kathryn G Lethbridge; Ruslan Sanishvili; Joanna Skiba; Konrad Kowalski; Yu Chen
Journal:  FEBS J       Date:  2017-11-20       Impact factor: 5.542

8.  Ligand-Induced Proton Transfer and Low-Barrier Hydrogen Bond Revealed by X-ray Crystallography.

Authors:  Derek A Nichols; Jacqueline C Hargis; Ruslan Sanishvili; Priyadarshini Jaishankar; Kyle Defrees; Emmanuel W Smith; Kenneth K Wang; Fabio Prati; Adam R Renslo; H Lee Woodcock; Yu Chen
Journal:  J Am Chem Soc       Date:  2015-06-22       Impact factor: 15.419

9.  Exploring the Mechanism of β-Lactam Ring Protonation in the Class A β-lactamase Acylation Mechanism Using Neutron and X-ray Crystallography.

Authors:  Venu Gopal Vandavasi; Kevin L Weiss; Jonathan B Cooper; Peter T Erskine; Stephen J Tomanicek; Andreas Ostermann; Tobias E Schrader; Stephan L Ginell; Leighton Coates
Journal:  J Med Chem       Date:  2015-12-02       Impact factor: 7.446

10.  Overview of the CCP4 suite and current developments.

Authors:  Martyn D Winn; Charles C Ballard; Kevin D Cowtan; Eleanor J Dodson; Paul Emsley; Phil R Evans; Ronan M Keegan; Eugene B Krissinel; Andrew G W Leslie; Airlie McCoy; Stuart J McNicholas; Garib N Murshudov; Navraj S Pannu; Elizabeth A Potterton; Harold R Powell; Randy J Read; Alexei Vagin; Keith S Wilson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18
View more
  2 in total

1.  Toho-1 β-lactamase: backbone chemical shift assignments and changes in dynamics upon binding with avibactam.

Authors:  Varun V Sakhrani; Rittik K Ghosh; Eduardo Hilario; Kevin L Weiss; Leighton Coates; Leonard J Mueller
Journal:  J Biomol NMR       Date:  2021-07-04       Impact factor: 2.582

2.  Structural basis to repurpose boron-based proteasome inhibitors Bortezomib and Ixazomib as β-lactamase inhibitors.

Authors:  Markus Perbandt; Nadine Werner; Andreas Prester; Holger Rohde; Martin Aepfelbacher; Winfried Hinrichs; Christian Betzel
Journal:  Sci Rep       Date:  2022-04-01       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.